Cold Chain Distribution Issues at Indo-Euro Pharma
Cold Chain Distribution Issues at Indo-Euro Pharma
Presented by:
Anitesh Das Syed Irfan Shreyansh Jain Sharad Jadhav
19020841168 19020841089 19020841084 19020841213
Content for IEP Case Study presentation
Solutions
A brief on the case
Data Source: COLD CHAIN DISTRIBUTION ISSUES AT INDO-EURO PHARMA Case Study Exhibit 1
Cold chains
As the spectrum of drugs became more complex and specialized, their specification also became more
complicated and drug-specific.
Srikumar was also aware that pharmaceutical companies could generally allow certain small
temperature excursions (changes) for a specified period of time, such as four hours, six hours, or 24
hours, depending on the chemical composition of the drug.
The primary purpose of thermal stability studies was to estimate the shelf-lives for TSDs and the
possible time out of refrigeration. The shelf-life of any drug was known as the phase of time in which
the drug would be effective if stored at recommended conditions.
Data on shelf lives and time out of refrigeration would provide information on whether temperature
excursions could be acceptable while keeping drugs’ medicinal properties intact.
One important point to consider for Mr. Srikumar was the ambiguity regarding “room temperature,”
which was commonly considered as “without refrigeration.” In the globalized world, drug products
travelled from one continent to another and “room temperature” might not necessarily be the same
throughout the shipping process.
A recent addition to supply technology was radio frequency identification devices (RFIDs) as a supply
chain facilitation tool in enabling companies to wirelessly capture data regarding the status of products in
transit.
The latest RFID tags could not only capture temperature data at regular time intervals, but could also
enable the recording and reading of data wirelessly while a product was in transit, without the container
being opened
Supply chain of IEP
IEP
Distribution
API
Networks
• Indo Euro Pharma bought several hundreds of API from diverse locations across the globe.
• Major issue pertaining to API was that they were temperature sensitive.
Distribution System
• IEP can try to reduce the number of intermediateries involved in the Distribution System to ensure the quality
and longevity of the drugs.
Warehouse dumping of expired medicines
• IEP can plan for the demand by collaborating the stakeholders involved using CPFR model and also by using
Predictive Analytics
• As IEP is using IOT device it will get the real time data for the demand of Drug and IEP will maintain the supply
accordingly and in case of any returned drugs, IEP must quickly figure out other location where there is demand
of these drugs in order to avoid holding costs.
Pharmacist
• IEP can train them for proper handling of TSD
• IEP can transport drugs to only those pharmacist who have proper infrastructure and equipments to store the
drug.
• IEP can do quality check quarterly/Half yearly of all the pharmacies it is supplying the drugs to.